Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Basel Medical Group Ltd ( (BMGL) ) is now available.
On April 11, 2025, Basel Medical Group Ltd’s subsidiary, Basel Medical Group Pte. Ltd., agreed to acquire all the issued shares of Bethesda Medical Pte. Ltd., a Singapore-incorporated medical company, from Silkroute Biomed Healthcare Pte. Ltd., and the transaction was completed on April 30, 2025, making Bethesda Medical a wholly owned indirect subsidiary. Basel Medical Group paid US$6.5 million upon completion, and the parties later agreed to waive the remaining US$1.5 million in deferred consideration, effectively fixing the total acquisition price at US$6.5 million, a move that consolidates the group’s control over Bethesda Medical while potentially improving the financial terms and strengthening its position in the Singapore healthcare services market.
More about Basel Medical Group Ltd
Basel Medical Group Ltd is a Singapore-based healthcare company that operates through subsidiaries to provide medical services, with a focus on expanding its footprint in the local medical and clinical services market through strategic acquisitions.
Average Trading Volume: 86,720
Technical Sentiment Signal: Strong Sell
Current Market Cap: $15.57M
For detailed information about BMGL stock, go to TipRanks’ Stock Analysis page.